Fuso Pharmaceutical Industries Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 0.99% vs 10.55% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 105.75% vs -3,893.33% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "14,042.00",
          "val2": "13,904.00",
          "chgp": "0.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "776.00",
          "val2": "571.00",
          "chgp": "35.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "102.00",
          "val2": "50.00",
          "chgp": "104.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.00",
          "val2": "-8,743.00",
          "chgp": "100.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "327.00",
          "val2": "-5,690.00",
          "chgp": "105.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.30%",
          "val2": "35.70%",
          "chgp": "-1.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 2.88% vs 9.31% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 161.16% vs -338.78% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "62,307.00",
          "val2": "60,563.00",
          "chgp": "2.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,258.00",
          "val2": "5,958.00",
          "chgp": "-11.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "328.00",
          "val2": "161.00",
          "chgp": "103.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "84.00",
          "val2": "-8,660.00",
          "chgp": "100.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,011.00",
          "val2": "-3,288.00",
          "chgp": "161.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "42.40%",
          "val2": "68.20%",
          "chgp": "-2.58%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

14,042.00

13,904.00

0.99%

Operating Profit (PBDIT) excl Other Income

776.00

571.00

35.90%

Interest

102.00

50.00

104.00%

Exceptional Items

3.00

-8,743.00

100.03%

Consolidate Net Profit

327.00

-5,690.00

105.75%

Operating Profit Margin (Excl OI)

19.30%

35.70%

-1.64%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 0.99% vs 10.55% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 105.75% vs -3,893.33% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

62,307.00

60,563.00

2.88%

Operating Profit (PBDIT) excl Other Income

5,258.00

5,958.00

-11.75%

Interest

328.00

161.00

103.73%

Exceptional Items

84.00

-8,660.00

100.97%

Consolidate Net Profit

2,011.00

-3,288.00

161.16%

Operating Profit Margin (Excl OI)

42.40%

68.20%

-2.58%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 2.88% vs 9.31% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 161.16% vs -338.78% in Mar 2025

All Annual Results